iX Biopharma's Secret Shortcut To The US Medical Market – 1H FY2026

Investor Exchange · Feb 9, 2026 · 18m · transcript

This episode explores iX Biopharma’s strategic pivot toward high-growth wellness and the U.S. compounding pharmacy market. We delve into their proprietary sublingual technology, which offers superior absorption and immediate commercial potential. Learn how a disciplined focus on longevity and clinical-ready assets is transforming their financial landscape. • Uncover the explosive momentum within the longevity segment and the flagship supplement captivating global consumers • Discover a capital-light pathway for rapid entry into the American healthcare market • Get updates on a breakthrough…